UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

The Rheumatology Drugs for COVID-19 Management: Which and When?

Journal of clinical medicine, 2021-02, Vol.10 (4), p.783

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a novel particle-based assay for detecting SLE-related autoantibodies

Heliyon, 2024-05, Vol.10 (10), p.e30767-e30767, Article e30767

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

Rheumatology (Oxford, England), 2020-06, Vol.59 (6), p.1306-1314

2020

Link zum Volltext

Verfügbarkeit prüfen

Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis

Journal of internal medicine, 2024-05, Vol.295 (5), p.651-667

2024

Link zum Volltext

Verfügbarkeit prüfen

Appendicular bleeding: an excepcional cause of lower hemorrhage

Revista española de enfermedades digestivas, 2016-07, Vol.108 (7), p.437-439

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository

Advances in rheumatology (London, England), 2021-10, Vol.61 (1), p.64-64, Article 64

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial

JMIR research protocols, 2023-10, Vol.12, p.e48387-e48387

2023

Link zum Volltext

Verfügbarkeit prüfen

Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohort

Arthritis research & therapy, 2020-11, Vol.22 (1), p.278-278, Article 278

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Arthritis & rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1407-1414

2023

Link zum Volltext

Verfügbarkeit prüfen

Fluctuation of Anti-Domain 1 and Anti-β 2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Arthritis & rheumatology (Hoboken, N.J.), 2023-06, Vol.75 (6), p.984-995

2023

Link zum Volltext

Verfügbarkeit prüfen

FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities

Clinical drug investigation, 2022-11, Vol.42 (11), p.949-964

2022

Link zum Volltext

Verfügbarkeit prüfen

Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019

ACR open rheumatology, 2021-04, Vol.3 (4), p.267-276

2021

Link zum Volltext

Verfügbarkeit prüfen

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

Autoimmunity reviews, 2019-04, Vol.18 (4), p.406-414

2019

Link zum Volltext

Verfügbarkeit prüfen

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Arthritis & rheumatology (Hoboken, N.J.), 2023-06, Vol.75 (6), p.984-995

2023

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry

Rheumatology (Oxford, England), 2021-12, Vol.60 (12), p.5883-5883

2021

Link zum Volltext

Verfügbarkeit prüfen

Treat to target in systemic lupus erythematosus

Revista Colombiana de Reumatologia, 2021-06, Vol.28 (suppl 1), p.101-106

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti Ro52 antibodies: One step further, but still not there yet

European journal of internal medicine, 2021-09, Vol.91, p.31-32

2021

Link zum Volltext

Verfügbarkeit prüfen

Treat-to-target in systemic lupus erythematosus: Where are we?

European journal of internal medicine, 2020-04, Vol.74, p.29-34

2020

Link zum Volltext

Verfügbarkeit prüfen

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis

Annals of the rheumatic diseases, 2022-04, Vol.81 (4), p.524

2022

Link zum Volltext

Verfügbarkeit prüfen

Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection

Frontiers in immunology, 2022-06, Vol.13, p.911979-911979

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment for refractory lupus nephritis: Rituximab vs triple target therapy

Autoimmunity reviews, 2019-12, Vol.18 (12), p.102406, Article 102406

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies

Rheumatology (Oxford, England), 2020-05, Vol.59 (Supplement_3), p.iii17-iii27

2020

Link zum Volltext

Verfügbarkeit prüfen

1821 - RELEVANCIA DEL FENOTIPO CLÍNICO-PATOLÓGICO Y DE LA ESPECIFICIDAD SEROLÓGICA EN LA PRESENTACIÓN CLÍNICA Y EL PRONÓSTICO A LARGO PLAZO EN UNA SERIE MONOCÉNTRICA DE 152 PACIENTES CON VASCULITIS ASOCIADA A ANCA

Revista clínica espanõla, 2023-11, Vol.223, p.S212-S213

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Rheumatology Drugs for COVID-19 Management: Which and When?

Evaluation of a novel particle-based assay for detecting SLE-related autoantibodies

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)

Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis

Appendicular bleeding: an excepcional cause of lower hemorrhage

Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository

Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial

Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohort

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository

Fluctuation of Anti-Domain 1 and Anti-β 2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities

Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry

Treat to target in systemic lupus erythematosus

Anti Ro52 antibodies: One step further, but still not there yet

Treat-to-target in systemic lupus erythematosus: Where are we?

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis

Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection

Treatment for refractory lupus nephritis: Rituximab vs triple target therapy

Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies

1821 - RELEVANCIA DEL FENOTIPO CLÍNICO-PATOLÓGICO Y DE LA ESPECIFICIDAD SEROLÓGICA EN LA PRESENTACIÓN CLÍNICA Y EL PRONÓSTICO A LARGO PLAZO EN UNA SERIE MONOCÉNTRICA DE 152 PACIENTES CON VASCULITIS ASOCIADA A ANCA

Suchergebnisse filtern